Evaluating Cardiovascular Event Reduction with Ezetimibe As an Adjunct to Simvastatin in 18,144 Patients after Acute Coronary Syndromes: Final Baseline Characteristics of the IMPROVE-IT Study Population.
American Heart Journal（2014）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要